Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-01

Clinical Trial Update: High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose dual therapy to clarithromycin-based triple therapy for treatment-naive Helicobacter pylori infection; study completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clarithromycin Triple Therapy
  • High-dose Dual Therapy

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED | Results posted: 2023-02-01